This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Two years after a task force recommended testing all baby boomers for the Hepatitis C virus (HCV), a new report finds that testing rates among that group are still very low.
Approximately 3.5 million people in the United States have chronic hepatitis C virus (HCV) infection. Most of those (80%) are “baby boomers” (born between 1945 and 1965), and most of them are unaware of their infections despite availability of treatments that may reduce their risk of HCV-related diseases, including chronic hepatitis, cirrhosis, and liver cancer.
The numbers are sobering: While the U.S. Centers for Disease Control and Prevention (CDC) estimates that 3.2 million Americans are currently infected with the Hepatitis C virus (HCV), the World Health Organization (WHO) further estimates that a staggering 130–150 million people globally have a chronic HCV infection and that 350 000 to 500 000 people die each year from HCV-related liver diseases.
